Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Cullinan's new data makes clearest case yet for autoimmune TCEs
When it comes to turning T-cell therapies to autoimmune diseases, CAR-Ts lead the way. But another red-hot modality is beginning to show potential.
James Waldron
Jun 6, 2026 5:15am
Lilly locks in vague, 5-program pact with Haisco worth up to $3B
Jun 1, 2026 7:26am
Inside City of Hope’s National Clinical Trials Platform
Brought to you by
City of Hope
US taps small biotech for experimental Ebola treatment
May 20, 2026 7:18pm
Pfizer ‘comfortable’ joining fights with hantavirus, Ebola: exec
May 20, 2026 5:05am
Incyte inks deal with Edison to train AI through drug discovery
May 19, 2026 10:30am
